S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial

G Stocker; S Lorenzen; T Ettrich; AL Herz; F Longo; A Kiani; M Venerito; J Trojan; R Mahlberg; N Moosmann; B Chibaudel; S Kubicka; Richard Greil; S Daum; M Geissler; J Larcher-Senn; G Keller; F Lordick; GM Haag

doi:10.1016/j.esmoop.2023.101572

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial

G Stocker, S Lorenzen, T Ettrich, AL Herz, F Longo, A Kiani, M Venerito, J Trojan, R Mahlberg, N Moosmann, B Chibaudel, S Kubicka, Richard Greil (Co-author), S Daum, M Geissler, J Larcher-Senn, G Keller, F Lordick, GM Haag

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	101572
Journal	ESMO OPEN
Volume	8
Issue number	3
DOIs	https://doi.org/10.1016/j.esmoop.2023.101572
Publication status	Published - 2023

Keywords

ADVANCED GASTRIC-CANCER
OXALIPLATIN-INDUCED NEUROPATHY
1ST-LINE TREATMENT
GASTROESOPHAGEAL ADENOCARCINOMA
ESOPHAGEAL CANCER
PLUS CHEMOTHERAPY
CISPLATIN
NONINFERIORITY
FLUOROURACIL
COMBINATION

Access to Document

10.1016/j.esmoop.2023.101572

Cite this

Stocker, G., Lorenzen, S., Ettrich, T., Herz, AL., Longo, F., Kiani, A., Venerito, M., Trojan, J., Mahlberg, R., Moosmann, N., Chibaudel, B., Kubicka, S., Greil, R., Daum, S., Geissler, M., Larcher-Senn, J., Keller, G., Lordick, F., & Haag, GM. (2023). S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial. ESMO OPEN, 8(3), 101572. https://doi.org/10.1016/j.esmoop.2023.101572

@article{724e4243f0674d2abd5f191d2cfa0cb3,

title = "S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial",

keywords = "ADVANCED GASTRIC-CANCER, OXALIPLATIN-INDUCED NEUROPATHY, 1ST-LINE TREATMENT, GASTROESOPHAGEAL ADENOCARCINOMA, ESOPHAGEAL CANCER, PLUS CHEMOTHERAPY, CISPLATIN, NONINFERIORITY, FLUOROURACIL, COMBINATION",

author = "G Stocker and S Lorenzen and T Ettrich and AL Herz and F Longo and A Kiani and M Venerito and J Trojan and R Mahlberg and N Moosmann and B Chibaudel and S Kubicka and Richard Greil and S Daum and M Geissler and J Larcher-Senn and G Keller and F Lordick and GM Haag",

note = "Greil: IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2023",

doi = "10.1016/j.esmoop.2023.101572",

language = "English",

volume = "8",

pages = "101572",

journal = "ESMO OPEN",

issn = "2059-7029",

publisher = "Elsevier ",

number = "3",

}

Stocker, G, Lorenzen, S, Ettrich, T, Herz, AL, Longo, F, Kiani, A, Venerito, M, Trojan, J, Mahlberg, R, Moosmann, N, Chibaudel, B, Kubicka, S, Greil, R, Daum, S, Geissler, M, Larcher-Senn, J, Keller, G, Lordick, F & Haag, GM 2023, 'S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial', ESMO OPEN, vol. 8, no. 3, pp. 101572. https://doi.org/10.1016/j.esmoop.2023.101572

TY - JOUR

T1 - S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinomaefinal results of the randomized AIO MATEO phase II trial

AU - Stocker, G

AU - Lorenzen, S

AU - Ettrich, T

AU - Herz, AL

AU - Longo, F

AU - Kiani, A

AU - Venerito, M

AU - Trojan, J

AU - Mahlberg, R

AU - Moosmann, N

AU - Chibaudel, B

AU - Kubicka, S

AU - Greil, Richard

AU - Daum, S

AU - Geissler, M

AU - Larcher-Senn, J

AU - Keller, G

AU - Lordick, F

AU - Haag, GM

N1 - Greil: IIIrd Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2023

Y1 - 2023

KW - ADVANCED GASTRIC-CANCER

KW - OXALIPLATIN-INDUCED NEUROPATHY

KW - 1ST-LINE TREATMENT

KW - GASTROESOPHAGEAL ADENOCARCINOMA

KW - ESOPHAGEAL CANCER

KW - PLUS CHEMOTHERAPY

KW - CISPLATIN

KW - NONINFERIORITY

KW - FLUOROURACIL

KW - COMBINATION

U2 - 10.1016/j.esmoop.2023.101572

DO - 10.1016/j.esmoop.2023.101572

M3 - Original Article

C2 - 37270871

SN - 2059-7029

VL - 8

SP - 101572

JO - ESMO OPEN

JF - ESMO OPEN

IS - 3

ER -